Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to examine the safety of a 14 day infusion of sodium nitrite, and
to study the pharmacokinetics of nitrite, during a 14 day infusion in patients with ruptured
cerebral aneurysms.
Phase:
Phase 2
Details
Lead Sponsor:
Hope Pharmaceuticals
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)